Guangzhou Pharma Says Chinese Medicine Is Our Advantage

The transcript discusses Guangzhou Farmers' joint venture with Israel's Teva, highlighting the impact of regulatory changes in China that facilitate foreign drugmakers' market access. It outlines Guangzhou's strategic response, emphasizing their strengths in Chinese medicine and the necessity for foreign companies to collaborate with local firms. The transcript also details Guangzhou's international expansion plans, including acquisitions and setting up plants overseas. Additionally, it covers future ventures with Media Group to automate drug production and dispensing, leveraging AI and robotic technologies.

What plans does Guangzhou Pharmaceutical have regarding automation in drug production?

What role does AI play in the future plans of Guangzhou Pharmaceutical?